CompaniesPevion Biotech

Pevion Biotech

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

2

As Collaborator

2

Total Enrollment

158

By Phase

PHASE1: 3PHASE1/PHASE2: 1

By Status

COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
Today
NCT01067131
Hover over trial bars to see details

Recent Trials

NCT01067131Lead Sponsor
Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection
PHASE1Completed
48 participants
Started: Mar 31, 2010 · Completed: Dec 31, 2012
NCT00513669Collaborator
Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
PHASE1Completed
50 participants
Started: Jan 31, 2008 · Completed: Mar 31, 2009
NCT00445419Lead Sponsor
Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides
PHASE1Completed
30 participants
Started: Dec 31, 2006 · Completed: Jun 30, 2008
NCT00408668Collaborator
Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen
PHASE1/PHASE2Completed
30 participants
Started: Aug 31, 2005 · Completed: Feb 28, 2006